Argenx Se

ARGXNasdaq Netherlands Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$53.687 B

$865.04 -1.17%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,883,306

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#1AmgenAMGN$222.2B
#2Gilead SciencesGILD$165.4B
#3Argenx SeARGX$53.7B
#4Revolution MedicinesRVMD$44.0B
#5BiogenBIIB$30.7B

Where these numbers come from

Share counts and financials for Argenx Se are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.